Glenmark Pharmaceuticals Ltd, a global research-led company operating across generics, specialty, and OTC segments in over 80 countries, delivered a stellar performance
Glenmark Q2 FY26 Earnings Results
Glenmark Pharmaceuticals Ltd, a global research-led company operating across generics, specialty, and OTC segments in over 80 countries, delivered a stellar performance in Q2FY26. Financial Highlights: Revenues rose 76.09% year-on-year to ₹6,047 crore from ₹3,434 crore. Total expenses increased 29.8%























